Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Oral administration of heat-killed mycobacterium manresensis delays progression toward active tuberculosis in C3HeB/FeJ mice

  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Marzo Escartín, Elena
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Díaz, Jorge
  • García, Vanessa
  • Varela, Ismael|||0000-0002-3825-372X
  • Vilaplana i Massaguer, Cristina
Low-dose tolerance using heat-killed mycobacteria has been tested as a means of stopping progression toward active tuberculosis (TB) lesions in a human-like murine model using C3HeB/FeJ mice. In the present study, we studied the effect of different treatment schedules with heat-killed non-tuberculous-mycobacteria (NTM) species when given orally, based on the hypothesis of generating oral tolerance. This study included M. manresensis, a new species belonging to the fortuitum group, present in drinking water. Oral treatment with M. manresensis for 2 weeks was able to induce a PPD-specific Tregs population, which has been related to a decrease in the neutrophilic infiltration found in TB lesions. Further mechanistic analysis using PPD-stimulated splenocytes links this 2-week treatment with heat-killed M. manresensis to IL-10 production and memory PPD-specific Tregs, and also to a weak PPD-specific global immune response stimulation, increasing IL-6, TNF, and IFN-γ production. In lungs, this treatment decreased the bacillary load, granulomatous infiltration and pro-inflammatory cytokines (TNF, IFN-γ, IL-6, and IL-17). Oral administration of M. manresensis during standard treatment for TB also significantly reduced the relapse of active TB after ending the treatment. Overall the data suggest that the use of heat-killed M. manresensis could be a new and promising tool for avoiding active TB induction and as adjunctive to TB treatment. This supports the usefulness of generating a new kind of protection based on a complex balanced immune response focused on both destroying the bacilli and including control of an excessive inflammatory response.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The lack of a big picture in tuberculosis, the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies

  • Vilaplana, Cristina|||0000-0002-2808-7270
  • Cardona, Pere-Joan|||0000-0001-5623-7873
This short review explores the large gap between clinical issues and basic science, and suggests why tuberculosis research should focus on redirect the immune system and not only on eradicating Mycobacterium tuberculosis bacillus. Along the manuscript, several concepts involved in human tuberculosis are explored in order to understand the big picture, including infection and disease dynamics, animal modeling, liquefaction, inflammation and immunomodulation. Scientists should take into account all these factors in order to answer questions with clinical relevance. Moreover, the inclusion of the concept of a strong inflammatory response being required in order to develop cavitary tuberculosis disease opens a new field for developing new therapeutic and prophylactic tools in which destruction of the bacilli may not necessarily be the final goal.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis, A Systematic Review

  • Kroesen, Vera Marie
  • Gröschel, Matthias I.|||0000-0002-2509-3034
  • Martinson, Neil
  • Zumla, Alimuddin|||0000-0002-5111-5735
  • Maeurer, Markus|||0000-0002-8436-8077
  • van der Werf, Tjip S.|||0000-0002-4824-1642
  • Vilaplana, Cristina|||0000-0002-2808-7270
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies, including non-steroidal anti-inflammatory drugs (NSAIDs), in contrast, target host factors to mitigate disease severity. In the present Systematic Review, we investigate whether NSAIDs display any effects as therapy of TB and discuss possible mechanisms of action of NSAIDs as adjunctive therapy of TB. Ten studies, seven preclinical studies in mice and three clinical trials, were included and systematically reviewed. Our results point toward a beneficial effect of NSAIDs as adjunct to current TB therapy regimens, mediated by decreased lung pathology balancing host-immune reaction. The determination of the best timing for their administration in order to obtain the potential beneficial effects needs further investigation. Even if the preclinical evidence requires clinical evaluation, NSAIDs might represent a potential safe, simple, and cheap improvement in therapy of TB.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia

  • Vashakidze, Sergo
  • Despuig, Albert
  • Gogishvili, Shota
  • Nikolaishvili, Keti
  • Shubladze, Natalia|||0000-0003-0580-9629
  • Avaliani, Zaza
  • Tukvadze, Nestan
  • Casals, Martí|||0000-0002-1775-8331
  • Caylà, Joan A..|||0000-0003-3891-111X
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Vilaplana, Cristina|||0000-0002-2808-7270
Our aim was to retrospectively compare clinical data and characteristics of removed lesions of the cohort of patients undergoing therapeutical surgery for their tuberculosis. Demographic and epidemiological details, clinical data, data on the surgery performed, macroscopic characteristics of the TB lesions removed, and outcome were recorded retrospectively from the 137 patients who underwent therapeutical surgery for their TB in Tbilisi, Georgia during 2014 and 2015. Men represented 70% of the included patients, presented more comorbidities and underwent operation earlier in terms of days between diagnostic and surgery. Women underwent operation at younger ages, and in MDR/XDR-TB cases, showed higher percentages of sputum conversion at >2 months and of fresh necrosis in the surgical specimens, suggesting a worse evolution. Half of cases were MDR/XDR-TB cases. In spite of being considered microbiologically cured according to WHO, a non despricable percentage of cases showed viable bacilli in the surgical specimen. Even if no causality could be statistically demonstrated, differences could be encountered according to gender and drug susceptibility of the responsible strains. According to our results, host factors such as gender, type of necrosis found in the lesions, size of lesions and presence of viable bacilli in the surgical specimen, should be included in future studies on therapeutical surgery of TB. As most of studies are done in MDR/XDR-TB, more data on DS-TB operated cases are needed. Our results also highlight that, in spite of achieving the microbiologically cured status, sterilization might not occur, and thus new biomarkers and new methods to evaluate the healing process of TB patients are urgently needed and radiological assays should be taken into account.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif

  • Molinos-Albert, Luis Manuel|||0000-0001-5447-6803
  • Bilbao, Eneritz
  • Agulló, Luis
  • Marfil, Sílvia|||0000-0003-0139-5000
  • García Rodríguez, Elisabet
  • Rodriguez de la Concepción, Maria Luisa|||0000-0002-6944-3462
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Nieto-Garai, Jon A.
  • Contreras, F. Xabier
  • Floor, Martin
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Villà Freixa, Jordi|||0000-0002-6359-3929
  • Lorizate, Maier
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Blanco, Julià|||0000-0002-2225-0217
The HIV-1 gp41 Membrane Proximal External Region (MPER) is recognized by broadly neutralizing antibodies and represents a promising vaccine target. However, MPER immunogenicity and antibody activity are influenced by membrane lipids. To evaluate lipid modulation of MPER immunogenicity, we generated a 1-Palmitoyl-2-oleoylphosphatidylcholine (POPC)-based proteoliposome collection containing combinations of phosphatidylserine (PS), GM3 ganglioside, holesterol (CHOL), sphingomyelin (SM) and the TLR4 agonist monophosphoryl lipid A (MPLA). A recombinant gp41-derived miniprotein (gp41-MinTT) exposing the MPER and a tetanus toxoid (TT) peptide that favors MHC-II presentation, was successfully incorporated into lipid mixtures (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pilot, double-blind, randomized, placebocontrolled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity

  • Montané Esteva, Eva|||0000-0002-1691-7652
  • Barriocanal, Ana María|||0000-0002-4159-519X
  • Arellano, Ana Lucía|||0000-0001-8601-3504
  • Valderrama, Angelica
  • Sanz, Yolanda
  • Pérez-Álvarez, Núria|||0000-0001-6582-1553
  • Cardona, Paula|||0000-0002-8613-9390
  • Vilaplana, Cristina|||0000-0002-2808-7270
  • Cardona, Pere-Joan|||0000-0001-5623-7873
Background. Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-like lesions. Methods. Double-blind, randomized, placebo-controlled Clinical Trial (51 volunteers included). Two different doses of NR and a placebo were tested, the randomization was stratified by Latent Tuberculosis Infection (LTBI)-positive (n = 21) and LTBI-negative subjects (n = 30). Each subject received 14 drinkable daily doses for 2 weeks. Results. All patients completed the study. The 46.3% of the overall reported adverse events (AE) were considered related to the investigational treatment. None of them were severe (94% were mild and 6% moderate). No statistical differences were found when comparing the median number of AE between the placebo group and both treatment groups. The most common AE reported were gastrointestinal events, most frequently mild abdominal pain and increase in stool frequency. Regarding the immunogenic response, both LTBI-negative and LTBI-positive volunteers treated with NR experienced a global increase on the Treg response, showed both in the population of CD25+CD39-, mainly effector Treg cells, or CD25+CD39+ memory PPD-specific Treg cells. Conclusion. This clinical trial demonstrates an excellent tolerability profile of NR linked to a significant increase in the population of specific effector and memory Tregs in the groups treated with NR in both LTBI-positive and negative subjects. NR shows a promising profile to be used to reduce the risk of active TB.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils

  • Fonseca, Kaori L.|||0000-0002-7048-9740
  • Maceiras, Ana Raquel|||0000-0001-7045-1331
  • Matos, Rita|||0000-0002-9186-3711
  • Simoes-Costa, Luisa
  • Sousa, Jeremy
  • Cá, Baltazar
  • Barros, Leandro
  • Fernandes, Ana Isabel
  • Mereiter, Stefan
  • Reis, Ricardo
  • Gomes, Joana|||0000-0002-8832-2703
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Rodriguez Martinez, Paula|||0000-0002-9001-2501
  • Martín-Céspedes, Montse
  • Vashakidze, Sergo
  • Gogishvili, Shota
  • Nikolaishvili, Keti
  • Appelberg, Rui
  • Gärtner, Fátima
  • Rodrigues, Pedro N. S.
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Reis, Celso A.|||0000-0002-0286-6639
  • Magalhães, Ana|||0000-0003-4863-6668
  • Saraiva, Margarida|||0000-0002-8180-1293
Modulation of immunity and disease by glycans is increasingly recognized. However, how host glycosylation shapes and is shaped by tuberculosis remains poorly understood. We show that deficiency in the glucosaminyl (N-acetyl) transferase 1 (Gcnt1), a key enzyme for core-2 O -glycans biosynthesis, drives susceptibility to Mycobacterium tuberculosis infection. The increased susceptibility of Gcnt1 deficient mice was characterized by extensive lung immune pathology, mechanistically related to neutrophils. Uninfected Gcnt1 deficient mice presented bone marrow, blood and lung neutrophilia, which further increased with infection. Blood neutrophilia required Gcnt1 deficiency in the hematopoietic compartment, relating with enhanced granulopoiesis, but normal cellular egress from the bone marrow. Interestingly, for the blood neutrophilia to translate into susceptibility to M. tuberculosis infection, Gnct1 deficiency in the stroma was also necessary. Complete Gcnt1 deficiency associated with increased lung expression of the neutrophil chemoattractant CXCL2. Lastly, we demonstrate that the transcript levels of various glycosyltransferase-encoding genes were altered in whole blood of active tuberculosis patients and that sialyl Lewis x, a glycan widely present in human neutrophils, was detected in the lung of tuberculosis patients. Our findings reveal a previously unappreciated link between Gcnt1, neutrophilia and susceptibility to M. tuberculosis infection, uncovering new players balancing the immune response in tuberculosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

  • Moreira-Teixeira, Lúcia|||0000-0002-4817-8196
  • Stimpson, Philippa J.
  • Stavropoulos, Evangelos
  • Hadebe, Sabelo|||0000-0002-6049-8395
  • Chakravarty, Probir
  • Ioannou, Marianna|||0000-0003-1304-2667
  • Aramburu, Iker Valle
  • Herbert, Eleanor|||0000-0002-2216-7771
  • Priestnall, Simon L.|||0000-0002-6027-1879
  • Suarez-Bonnet, Alejandro|||0000-0003-0296-5896
  • Sousa, Jeremy
  • Fonseca, Kaori L.|||0000-0002-7048-9740
  • Wang, Qian
  • Vashakidze, Sergo
  • Rodriguez Martinez, Paula|||0000-0002-9001-2501
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Saraiva, Margarida|||0000-0002-8180-1293
  • Papayannopoulos, Venizelos
  • O'Garra, Anne|||0000-0001-9845-6134
Tuberculosis (TB) is a leading cause of mortality due to infectious disease, but the factors determining disease progression are unclear. Transcriptional signatures associated with type I IFN signalling and neutrophilic inflammation were shown to correlate with disease severity in mouse models of TB. Here we show that similar transcriptional signatures correlate with increased bacterial loads and exacerbate pathology during Mycobacterium tuberculosis infection upon GM-CSF blockade. Loss of GM-CSF signalling or genetic susceptibility to TB (C3HeB/FeJ mice) result in type I IFN-induced neutrophil extracellular trap (NET) formation that promotes bacterial growth and promotes disease severity. Consistently, NETs are present in necrotic lung lesions of TB patients responding poorly to antibiotic therapy, supporting the role of NETs in a late stage of TB pathogenesis. Our findings reveal an important cytokine-based innate immune effector network with a central role in determining the outcome of M. tuberculosis infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis

  • Kroesen, Vera Marie
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • García, Eric
  • Rosales, Yaiza
  • Díaz, Jorge
  • Martín-Céspedes, Montse
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Vilaplana, Cristina|||0000-0002-2808-7270
An excessive, non-productive host-immune response is detrimental in active, chronic tuberculosis (TB) disease as it typically leads to tissue damage. Given their anti-inflammatory effect, non-steroidal anti-inflammatory drugs can potentially attenuate excessive inflammation in active TB disease. As such, we investigated the prophylactic and therapeutic effect of low-dose aspirin (LDA) (3 mg/kg/day), either alone or in combination with common anti-TB treatment or BCG vaccination, on disease outcome in an experimental murine model of active TB. Survival rate, bacillary load (BL) in lungs, and lung pathology were measured. The possible mechanism of action of LDA on the host's immune response was also evaluated by measuring levels of CD5L/AIM, selected cytokines/chemokines and other inflammatory markers in serum and lung tissue. LDA increased survival, had anti-inflammatory effects, reduced lung pathology, and decreased bacillary load in late-stage TB disease. Moreover, in combination with common anti-TB treatment, LDA enhanced survival and reduced lung pathology. Results from the immunological studies suggest the anti-inflammatory action of LDA at both a local and a systemic level. Our results showed a systemic decrease in neutrophilic recruitment, decreased levels of acute-phase reaction cytokines (IL-6, IL-1β, and TNF-α) at late stage and a delay in the decrease in T cell response (in terms of IFN-γ, IL-2, and IL-10 serum levels) that occurs during the course of Mycobacterium tuberculosis infection. An anti-inflammatory milieu was detected in the lung, with less neutrophil recruitment and lower levels of tissue factor. In conclusion, LDA may be beneficial as an adjunct to standard anti-TB treatment in the later stage of active TB by reducing excess, non-productive inflammation, while enhancing Th1-cell responses for elimination of the bacilli.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multiple Consecutive Infections Might Explain the Lack of Protection by BCG

  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Vilaplana, Cristina|||0000-0002-2808-7270
Although contacts between tuberculosis patients may result in multiple consecutive infections (MCI), no experimental animal models consider this fact when used in basic studies. Moreover, the current TB vaccine (BCG) has demonstrated a limited protection in humans. In this study we evaluate the effect of tuberculosis MCI by way of a simple mathematical analysis using data from the low dose aerosol murine experimental model. The results show that a higher number of, or shorter intervals between, multiple consecutive infections reduce the protective effect of BCG. This is due to both the increase in bacillary load at the stationary level of the infection, and the protective immune response induced by the infection itself. This factor must therefore be taken into account when designing new prophylactic strategies as candidate vaccines for the replacement of BCG.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

To Achieve an Earlier IFN-γ Response Is Not Sufficient to Control Mycobacterium tuberculosis Infection in Mice

  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Prats, Clara|||0000-0002-1398-7559
  • Marzo, Elena
  • Barril, Carles|||0000-0002-4612-5533
  • Vegué, Marina
  • Díaz, Jorge
  • Valls, Joaquim|||0000-0002-2346-5041
  • López Codina, Daniel|||0000-0002-0408-4526
  • Cardona, Pere-Joan|||0000-0001-5623-7873
The temporo-spatial relationship between the three organs (lung, spleen and lymph node) involved during the initial stages of Mycobacterium tuberculosis infection has been poorly studied. As such, we performed an experimental study to evaluate the bacillary load in each organ after aerosol or intravenous infection and developed a mathematical approach using the data obtained in order to extract conclusions. The results showed that higher bacillary doses result in an earlier IFN-γ response, that a certain bacillary load (BL) needs to be reached to trigger the IFN-γ response, and that control of the BL is not immediate after onset of the IFN-γ response, which might be a consequence of the spatial dimension. This study may have an important impact when it comes to designing new vaccine candidates as it suggests that triggering an earlier IFN-γ response might not guarantee good infection control, and therefore that additional properties should be considered for these candidates.